HK Stock Market Move | YUNJI (02670) rose more than 13% in intraday trading, reaching a new all-time high. Smart body application revenue nearly doubled year-on-year.
Yunji Inc. (02670) rose more than 13% during trading, reaching a high of 225.2 Hong Kong dollars, setting a new all-time high. As of the time of writing, it has increased by 7.49% to 213.8 Hong Kong dollars, with a turnover of 1013.36 million Hong Kong dollars.
YUNJI (02670) rose more than 13% during trading, reaching a high of HK$225.2, setting a new historical high. As of the time of writing, it is up 7.49% at HK$213.8, with a trading volume of HK$1013.36 million.
In terms of news, YUNJI released its annual performance report, achieving an operating income of RMB 3.01 billion, a year-on-year increase of 23.1%. In particular, the revenue from the "intelligent body application" representing the company's strategic direction increased by 194.1% year-on-year. The announcement stated that this marks the company's strategic shift towards data-centric and service-driven algorithms entering the commercial value realization period. In addition, the company aims to achieve a year-on-year growth of 92.1% in revenue from outside mainland China by 2025.
Industrial released a research report stating that YUNJI is a leader in the Chinese hotel scene service Siasun Robot & Automation, benefiting from early-mover advantages, customer and data resource accumulation, and diversified layout in various scenes including healthcare and factories. The company is currently focused on product sales of Siasun Robot & Automation as its performance base, while the subscription and service charges for intelligent body applications offer long-term growth potential.
Related Articles

VINCENT MED (01612) announces annual performance, with shareholders' profit reaching 104 million Hong Kong dollars, a year-on-year increase of 50.91%. Final dividend per share is 2.6 Hong Kong cents.

TVB (00511) announces its performance for 2025 with a net profit attributable to shareholders of HKD 59.289 million, turning losses into profits year-on-year.

TRANSTECH (09963): Zou Liming appointed as Executive Director and Chief Executive Officer.
VINCENT MED (01612) announces annual performance, with shareholders' profit reaching 104 million Hong Kong dollars, a year-on-year increase of 50.91%. Final dividend per share is 2.6 Hong Kong cents.

TVB (00511) announces its performance for 2025 with a net profit attributable to shareholders of HKD 59.289 million, turning losses into profits year-on-year.

TRANSTECH (09963): Zou Liming appointed as Executive Director and Chief Executive Officer.

RECOMMEND

Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026

Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026

Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026


